Navigation Links
HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients
Date:10/15/2008

w York Presbyterian-Hospital/Columbia University Medical Center and Principal Investigator of the HORIZONS AMI trial.

"Outcomes from prior registry studies of drug-eluting stents compared to bare-metal stents in AMI patients have been conflicting; this is the first prospective, large, international randomized clinical trial and provides conclusive evidence on this subject," continued Dr. Stone. "The findings from the HORIZONS AMI trial will have a major impact on how decisions are made regarding drug-eluting and bare-metal stents in the highest risk patients in this trial, those in the early hours of a heart attack. This study removes much of the uncertainty and concern about the efficacy and safety of drug-eluting stents in this clinical setting. Moreover, all of the patients in this trial will be followed for five years to ensure that these favorable results are maintained."

One-year results showed comparable overall safety outcomes (death, stroke, myocardial infarction or stent thrombosis) between the two treatment groups (8.0 percent for the Express(R) bare-metal stent versus 8.1 percent for the TAXUS Express(R) Stent, p=0.92). There was a statistically significant 41 percent reduction in revascularization in the TAXUS Express group (7.5 percent for the Express Stent versus 4.5 percent for the TAXUS Express Stent, p=0.002).

"Our investments in drug-eluting stent clinical trials are designed to provide the medical community with relevant data they can use in combination with their own clinical judgment to decide optimal treatment strategies for patients," said Donald S. Baim, M.D., Chief Medical and Scientific Officer of Boston Scientific. "The HORIZONS trial provides valuable insight into the benefits of the TAXUS Express Stent in a high-risk patient population."

The safety and effectiveness of the TAXUS Express Stent has not been established in patients with AMI.

Boston Scientific is a worldwide developer, manufacturer and mar
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015 Townsend Design announced the ... Reliever, a soft shell single-upright osteoarthritis (OA) knee brace. ... relieve pain by reducing load on the side of ... Sales of the product in other countries will begin ... sewn-in integrated semi rigid frame and quick release buckles ...
(Date:5/21/2015)... Md. , May 21, 2015 ... open innovation competition designed to bring promising medical ... Heritage Provider Network (HPN) in collaboration with the ... for Advancing Innovation (CAI).  The winning teams were ... and live pitches and will move forward to ...
(Date:5/21/2015)... BOSTON , May 21, 2015  Juniper ... specialty pharmaceutical company focused on developing therapeutics that ... announced that CEO Frank Condella will ... as follows:Date: , Thursday, June 4, 2015Time: , ... & archive): , www.juniperpharma.com, under  ,Investor, ...
Breaking Medicine Technology:Townsend Announces Launch Of New Osteoarthritis Knee Brace 2Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 2Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 3Neuro Startup Challenge selects 13 winning teams to launch startups for unlicensed NIH technologies to improve brain health 4Juniper Pharmaceuticals to Present at Jefferies 2015 Global Healthcare Conference on June 4, 2015 2
... ULURU Inc. (NYSE AMEX: ... development of a portfolio of wound management and oral ... for investment commitments with Ironridge Global BioPharma and its ... transactions, subject to certain conditions, to purchase common and ...
... Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), ... Data Safety Monitoring Board (DSMB) recently completed a ... Soligenix,s confirmatory Phase 3 clinical trial of orBec® ... acute gastrointestinal Graft-versus-Host disease (GI GVHD). ...
Cached Medicine Technology:ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 2ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 2Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 3Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 4Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 5Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD 6
(Date:5/22/2015)... (PRWEB) May 22, 2015 A new ... featuring experts in the field of Physical Therapy. ... that takes the mystery out of physical therapy and ... range of motion for a variety of ailments and ... establish a personalized exercise plan that enhances daily activities ...
(Date:5/22/2015)... May 22, 2015 Yisrayl Hawkins, Pastor and ... released a new letter calling on religious leaders to make ... which was published on his blog, discusses the history of ... needed to stop it. Yisrayl says mankind was created to ... experienced in today’s society. , “Yahweh created mankind, according ...
(Date:5/21/2015)... World Patent Marketing, a vertically integrated ... Motor Guide, a boat patent that aims to give ... boating industry has reached an annual revenue of $36.7 ... of World Patent Marketing , "Americans are taking ... steady growth of seven percent in new sales through ...
(Date:5/21/2015)... The Johns Hopkins Alliance for Science and Technology ... Board has selected a research project at the Veterans ... two $50,000 Abell Foundation Award for Excellence in Innovation ... Developed by the VA Maryland Exercise and Robotics ... Maryland School of Medicine and Massachusetts Institute of Technology ...
(Date:5/21/2015)... Irvine, CA (PRWEB) May 21, 2015 Bird ... industrial and residential applications recently added new sizes of the ... solutions. The affordable stainless steel bird spike is ... from landing or roosting on roof lines, parapet walls, I-beams, ... 10, 24, 50 and 100 foot boxes, allowing customers to ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 2Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 3
... of blood vessels in the eyes may offer insight into stroke ... react to high blood pressure, a major risk factor for stroke ... known as Atacand, improves blood flow in the eye, which can ... the lining of the vessel walls and plays a key role ...
... COPD is a term to describe conditions such as ... of airflow // and gradual loss of lung function ... leading cause of death in the United States. ... diagnose patients with chronic obstructive pulmonary disease earlier.Researchers compared ...
... growing waistline is bad for your health, but now a ... for your health.// ,When a company downsizes, it ... workers are concerned about their job and their future. But ... also have health problems. Workplaces that expanded their number of ...
... cells located at the base of the hair follicle. ... phases. In many people with hair loss, however, // ... number of abnormal follicles entering longer resting phases and ... the University of Pennsylvania School of Medicine have isolated ...
... has been done on patients for 10 years. The ... the more conventional large incision. While the patient clearly ... long-term benefits have not previously been studied. ,Laparoscopic ... choice after results from a new study. The study ...
... the initial mammogram immediately so any follow-up tests can ... 5 percent and 11 percent of all screening mammograms ... a follow-up mammogram. Many abnormal mammograms turn out to ... breast cancer diagnosis within one year. Even when follow-ups ...
Cached Medicine News:
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: